Inactive Instrument
Cytophage Technologies Ltd. Stock
Stocks
CPTC.F
CA2328211081
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Steven Theriault
CEO | Chief Executive Officer | - | 2024-02-01 |
James Kinley
DFI | Director of Finance/CFO | 48 | 2026-01-19 |
| Director | Title | Age | Since |
|---|---|---|---|
Steven Theriault
BRD | Director/Board Member | - | 2024-02-01 |
Robert Gabor
BRD | Director/Board Member | - | 2024-02-01 |
Michael Cochrane
BRD | Director/Board Member | - | 2024-04-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 14M | |
| +0.11% | +1.71% | +63.52% | +117.61% | 1,055B | |
| +0.27% | +0.92% | +51.33% | +73.35% | 654B | |
| +0.73% | +0.68% | +20.70% | +74.90% | 467B | |
| -1.36% | -0.39% | +40.20% | +41.03% | 348B | |
| +1.34% | +5.47% | +23.37% | +31.30% | 275B | |
| -0.48% | -0.06% | +13.56% | +12.36% | 258B | |
| +0.85% | +6.35% | +53.17% | +54.39% | 224B | |
| +0.85% | +1.10% | +35.78% | +101.82% | 187B | |
| -0.30% | -10.41% | -27.62% | -61.04% | 171B | |
| Average | +0.12% | +0.69% | +30.45% | +49.52% | 404.26B | |
| Weighted average by Cap. | -0.05% | +1.11% | +40.69% | +69.79% |
Employees
-
Sector
Pharmaceuticals
